Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chandra Sekhar, Chirumamilla"'
Autor:
Ajay Palagani, Ken Op de Beeck, Stefan Naulaerts, Jolien Diddens, Chandra Sekhar Chirumamilla, Guy Van Camp, Kris Laukens, Karen Heyninck, Sarah Gerlo, Pieter Mestdagh, Joke Vandesompele, Wim Vanden Berghe
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113842 (2014)
Glucocorticoids (GCs) selectively trigger cell death in the multiple myeloma cell line MM1S which express NR3C1/Glucocorticoid Receptor (GR) protein, but fail to kill MM1R cells which lack GR protein. Given recent demonstrations of altered microRNA p
Externí odkaz:
https://doaj.org/article/55383d82c97441059c5917eabd8cfb0e
Autor:
Fazil Mobashar Hussain Urf Turabe, Ken Declerck, Ajay Palagani, Kris Laukens, Xaveer Van Ostade, Pieter Van Vlierberghe, Wim Vanden Berghe, Emilie Logie, Claudina Perez-Novo, Bart Cuypers, Fritz Offner, Nicolas De Neuter, Priyanka Shaw, Annemie Bogaerts, Savithri Rangarajan, Navin Kumar Verma, Chandra Sekhar Chirumamilla
Publikováno v:
Cancers
CANCERS
Cancers, Vol 13, Iss 1618, p 1618 (2021)
Volume 13
Issue 7
CANCERS
Cancers, Vol 13, Iss 1618, p 1618 (2021)
Volume 13
Issue 7
Simple Summary Glucocorticoid therapy resistance in B-cell malignancies is often associated with constitutive activation of tyrosine kinases. Novel anticancer drugs targeting hyperactivated tyrosine kinases, such as Bruton's tyrosine kinase (BTK), ha
Autor:
Siu Kwan Sze, Claudina Perez-Novo, Navin Kumar Verma, Wim Vanden Berghe, Chandra Sekhar Chirumamilla, Brandon Han Siang Wong, Mobashar Hussain Urf Turabe Fazil, Sunil Kumar
Publikováno v:
The Journal of Biological Chemistry
Journal of biological chemistry
Journal of biological chemistry
The steroidal lactone withaferin A (WFA) is a dietary phytochemical, derived from Withania somnifera. It exhibits a wide range of biological properties, including immunomodulatory, anti-inflammatory, antistress, and anticancer activities. Here we inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d6d3205392f734f50cbfb69dbbe5f0b
https://hdl.handle.net/10356/161091
https://hdl.handle.net/10356/161091
Autor:
Ryabtsova Oksana, Jurgen Joossens, Marinus Verbeeck, Pieter Van der Veken, Xaveer Van Ostade, Winnok H. De Vos, Nadia Bougarne, Chandra Sekhar Chirumamilla, Kris Gevaert, Balu Kamaraj, Bart Ruttens, Hans De Winter, Karolien De Bosscher, Wim Vanden Berghe, Annemie Bogaerts, Koen Augustyns, Ajay Palagani, René Houtman
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO2-5
Publikováno v:
Proceedings of the Nutrition Society
Despite the worldwide research efforts to combat cancer, it remains a leading cause of death. Although various specific kinase inhibitors already have been approved for clinical cancer treatment, occurrence of intrinsic or acquired resistance and int
Autor:
Chandra Sekhar, Chirumamilla, Mobashar Hussain Urf Turabe, Fazil, Claudina, Perez-Novo, Savithri, Rangarajan, Rik, de Wijn, Padma, Ramireddy, Navin Kumar, Verma, Wim, Vanden Berghe
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1930
T-Lymphocyte kinases are important checkpoints that control T-cell motility by regulating a diverse range of signal transduction pathways. The distinct configuration of kinase events in T-cell could be used to fingerprint the status of T-cells. Howev
Autor:
Wim Vanden Berghe, Claudina Perez-Novo, Chandra Sekhar Chirumamilla, Mobashar Hussain Urf Turabe Fazil, Navin Kumar Verma, Padma Ramireddy, Rik de Wijn, Savithri Rangarajan
Publikováno v:
Methods in Molecular Biology ISBN: 9781493990351
Methods in molecular biology
Methods in molecular biology
T-Lymphocyte kinases are important checkpoints that control T-cell motility by regulating a diverse range of signal transduction pathways. The distinct configuration of kinase events in T-cell could be used to fingerprint the status of T-cells. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ca56244abb223cd1a3839bfb67c791
https://doi.org/10.1007/978-1-4939-9036-8_13
https://doi.org/10.1007/978-1-4939-9036-8_13
Autor:
Debora Curci, Giuliana Decorti, Francesca Ghiringhelli, Federico Dapiaggi, Nadine Martinet, Maurizio Sironi, Gabriele Stocco, Egle M. Beccalli, Alain Burger, Marianna Lucafò, Wim Vanden Berghe, Chandra Sekhar Chirumamilla, Daniele Passarella, Benoît Y. Michel, Stefano Pieraccini, Patrick Balaguer, Michael S. Christodoulou
Publikováno v:
ACS medicinal chemistry letters 9 (2018): 339–344. doi:10.1021/acsmedchemlett.7b00527
info:cnr-pdr/source/autori:Christodoulou, Michael S.; Dapiaggi, Federico; Ghiringhelli, Francesca; Pieraccini, Stefano; Sironi, Maurizio; Lucafo, Marianna; Curci, Debora; Decorti, Giuliana; Stocco, Gabriele; Chirumamilla, Chandra Sekhar; Vanden Berghe, Wim; Balaguer, Patrick; Michel, Benoit Y.; Burger, Alain; Beccalli, Egle M.; Passarella, Daniele; Martinet, Nadine/titolo:Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor/doi:10.1021%2Facsmedchemlett.7b00527/rivista:ACS medicinal chemistry letters/anno:2018/pagina_da:339/pagina_a:344/intervallo_pagine:339–344/volume:9
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters, American Chemical Society, 2018, 9 (4), pp.339-344. ⟨10.1021/acsmedchemlett.7b00527⟩
ACS medicinal chemistry letters
info:cnr-pdr/source/autori:Christodoulou, Michael S.; Dapiaggi, Federico; Ghiringhelli, Francesca; Pieraccini, Stefano; Sironi, Maurizio; Lucafo, Marianna; Curci, Debora; Decorti, Giuliana; Stocco, Gabriele; Chirumamilla, Chandra Sekhar; Vanden Berghe, Wim; Balaguer, Patrick; Michel, Benoit Y.; Burger, Alain; Beccalli, Egle M.; Passarella, Daniele; Martinet, Nadine/titolo:Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid Receptor/doi:10.1021%2Facsmedchemlett.7b00527/rivista:ACS medicinal chemistry letters/anno:2018/pagina_da:339/pagina_a:344/intervallo_pagine:339–344/volume:9
ACS Medicinal Chemistry Letters
ACS Medicinal Chemistry Letters, American Chemical Society, 2018, 9 (4), pp.339-344. ⟨10.1021/acsmedchemlett.7b00527⟩
ACS medicinal chemistry letters
International audience; Glucocorticoid receptor (GCR) transactivation reporter gene assays were used as an initial high-throughput screening on a diversified library of 1200 compounds for their evaluation as GCR antagonists. A class of imidazo[2,1-b]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::874dacf5be1eb1799219dbd3853a5555
http://www.cnr.it/prodotto/i/397635
http://www.cnr.it/prodotto/i/397635
Autor:
Katarzyna Szarc vel Szic, Laurent-Emmanuel Monfoulet, Chandra Sekhar Chirumamilla, Ken Declerck, Maija Lahtela-Kakkonen, Clarissa Gerhäuser, Sylvain Claude, Wim Vanden Berghe, Dragan Milenkovic, Annette M. van de Sandt, Christine Morand, Marc W. Merx, Simone Gorressen, Malte Kelm
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2018, 8 (1), ⟨10.1038/s41598-018-33959-x⟩
Scientific reports, vol 8, iss 1
Scientific reports
2nd COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives . 1 (8), 2017; 2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives, Thessalonique, GRC, 2017-09-20-2017-09-21
2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives
2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives, Sep 2017, Thessalonique, Greece. 2017
Scientific Reports 1 (8), . (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-17 (2018)
2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives, Sep 2017, Thessalonique, Greece. Scientific Reports, 8 (1), 2017, 2nd COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives. ⟨10.1038/s41598-018-33959-x⟩
Scientific Reports, 2018, 8 (1), ⟨10.1038/s41598-018-33959-x⟩
Scientific Reports, Nature Publishing Group, 2018, 8 (1), ⟨10.1038/s41598-018-33959-x⟩
Scientific reports, vol 8, iss 1
Scientific reports
2nd COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives . 1 (8), 2017; 2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives, Thessalonique, GRC, 2017-09-20-2017-09-21
2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives
2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives, Sep 2017, Thessalonique, Greece. 2017
Scientific Reports 1 (8), . (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-17 (2018)
2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives, Sep 2017, Thessalonique, Greece. Scientific Reports, 8 (1), 2017, 2nd COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives. ⟨10.1038/s41598-018-33959-x⟩
Scientific Reports, 2018, 8 (1), ⟨10.1038/s41598-018-33959-x⟩
Presented at 2. COST POSITIVe Scientific Workshop on « Omics breakthroughs in the Health effects of plant food bioactives ; Thessalonique (Grèce) - (2017-09-20 - 2017-09-21) / Workshop (Prodinra 408917); International audience; Although vasculo-pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59faa3d1809ecc6138a3b50643bb3eb9
https://hal.inrae.fr/hal-02629289
https://hal.inrae.fr/hal-02629289
Autor:
Simon Van Herck, José Pedro Friedmann Angeli, Bruno G. De Geest, Maija Lahtela-Kakkonen, Guy Van Camp, Irina Ingold, Karen Heyninck, Wim Vanden Berghe, Valerian E. Kagan, Dmitri V. Krysko, Peter Vandenabeele, Eline Meul, Sze Men Choi, Yulia Y. Tyurina, Ken Declerck, Simone Fulda, Bartosz Wiernicki, Behnaz Ahangarian Abhari, Tom Vanden Berghe, Hülya Bayır, Feng Qu, Paul G Ekert, Chandra Sekhar Chirumamilla, Behrouz Hassannia, Marcus Conrad
Publikováno v:
J. Clin. Invest. 128, 3341-3355 (2018)
The journal of clinical investigation
JOURNAL OF CLINICAL INVESTIGATION
The journal of clinical investigation
JOURNAL OF CLINICAL INVESTIGATION
High-risk neuroblastoma is a devastating malignancy with very limited therapeutic options. Here, we identify withaferin A (WA) as a natural ferroptosis-inducing agent in neuroblastoma, which acts through a novel double-edged mechanism. WA dose-depend